SCHEMBL24596189

SCHEMBL24596189

CNc1nc2c(=O)n(-c3ccccc3Cl)c3nc(C(F)(F)F)ccc3c2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24596200 0.87 MAT2A (0.57) MAT2A
SCHEMBL24596273 0.85 MAT2A (0.58) MAT2A
SCHEMBL24596293 0.84 MAT2A (0.57) MAT2A
SCHEMBL29789960 0.84 MAT2A (0.57) MAT2A
SCHEMBL24596191 0.81 MAT2A (0.53) MAT2A
SCHEMBL24596241 0.81 MAT2A (0.60) MAT2A
SCHEMBL24122943 0.80 MAT2A (0.68) MAT2A
SCHEMBL24122524 0.79 MAT2A (0.67) MAT2A
SCHEMBL24596307 0.79 MAT2A (0.58) MAT2A
SCHEMBL24596304 0.78 MAT2A (0.56) MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273146-A1 TRICYCLIC COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2023-11-08 EP disclosed
WO-2022143864-A1 TRICYCLIC COMPOUND AND USE THEREOF 江苏先声药业有限公司 2022-07-07 WO disclosed